← HB3834 bill details

Other recorded roll call

HB3834

Senate: Appropriations Committee: DO PASS AMENDED CS

Ibogaine clinical trials; Oklahoma Breakthrough Therapy Act; terms; requirements for drug developers; contractual terms; intellectual property rights; reports; intellectual property account; effective date.

Passed Senate April 22, 2026

20Yea
0Nay
0Not voting
0Absent
Source provenance